(Total Views: 700)
Posted On: 10/15/2020 12:45:11 PM
Post# of 145258
Nice article. Excerpt: leronlimab offers a potential long acting, monotherapy maintenance regimen. Similar to ibalizumab, leronlimab has also demonstrated notable virologic suppression results in treatment-experienced, MDR HIV patients who have limited options available. Leronlimab has received fast-track designation,
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)